Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: Results of the I-inSYST survey

Journal of Hypertension

Volumn 26, Issue 10, 2008, Pages 2057-2063

  Van Der Niepen, Patricia ^a   Giot, Christophe ^b   Van De Borne, Philippe ^c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b BRISTOL MYERS SQUIBB   (United States)

^c ERASME HOSPITAL   (Belgium)

Author keywords

blood pressure control; guidelines; hypertension; isolated systolic hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BELGIUM; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; HYPERTENSION; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BELGIUM; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 58149121004     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32830a9a49     Document Type: Article

References (30)

1. Guidelines committee. 2007 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2007; 25:1105-1187.
2. Staessen J, Gasowski J, Wang J, Thijs L, Hond E, Boissel J, et al. Risks of untreated and treated isolated systolic hypertension in the elderly:meta-analysis of outcome trials. Lancet 2000; 355:865-872.
3. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971; 17:335-346.
4. Wang JG, Staessen JA, Franklin SS, Fagard R, Gueyf?er F. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45:907-913.
5. Waeber B. Trials in isolated systolic hypertension: an update. Curr Hypertens Rep 2003; 5:329-336.
6. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the Health Examination Surveys 1960 to 1991. Hypertension 1995; 26:60-69.
7. Erdine S. How well is hypertension controlled in Europe? European Society of Hypertension Scienti?c Newsletter 2007; 8:n8 3 (http://www.eshonline.org/ education/newsletter/2007-3.pdf).
8. Staessen J, Amery A, Fagard R. Editorial review: isolated systolic hypertension in the elderly. J Hypertens 1990; 8:393-405.
9. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994; 23:275-285.
10. Fagard RH, Van den Enden M. Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care. J Hum Hypertens 2003; 17:681-687.
11. Mancia G, Bombelli M, Lanzarotti A, Grassi G, Cesana GC, Zanchetti A, Sega R. Systolic versus Diastolic Blood Pressure Control in the Hypertensive Patients of the PAMELA Population. Arch Intern Med 2002; 162:582-586.
12. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36:594-599.
13. Franklin SS, Jacobs MJ,Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001; 37:869-874.
14. Fleiss JL. Statistical methods for rates and proportions, second edition. New York: Wiley; 1981. pp. 13-15.
15. Fagard RH, Van Den Enden M, Leeman M,Warling X. Survey on treatment of hypertension and implementation of World Health Organization/ International Society of Hypertension risk strati?cation in primary care in Belgium. J Hypertens 2002; 20:1297-1302.
16. De Backer G, Myny K, De Henauw S, Doyen Z, Van Oyen H, Tafforeau J, Kornitzer M. Prevalence, awareness, treatment and control of arterial hypertension in an elderly population in Belgium. J Hum Hypertens 1998; 12:701-706.
17. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E, et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25:1491-1498.
18. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24:1187-1192.
19. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al. Angiotensin II receptor blockade reduces new-onset atrial ?brillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45:712-719.
20. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caul?eld M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendro?umethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366:895-906.
21. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304:405-412.
22. NICE. Hypertension: management of hypertension in adults in primary care: partial update. London: National Institute for Clinical Excellence; 2006.
23. Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M. Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study. J Hypertens 2004; 22:1221-1229.
24. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
25. Staessen JA,Wang JG, Thijs L, Fagard R. Overview of the outcome trials in older patients with isolated systolic hypertension. J Hum Hypertens 1999; 13:859-863.
26. Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C, et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens 2003; 21:509-517.
27. Vasan RS, Kannel WB. Are guidelines effectively guiding antihypertensive therapy? Am J Cardiol 2007; 100:143-144.
28. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: the Framingham Risk score functions. Stat Med 2004; 23:1631-1660.
29. IPH/EPI reports 2006-036 and 037. www.iph.fgov.be/epi.
30. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003-1010.